// WA med startup Noisy Guts has won $1M from the highly competitive federal government’s Biomedical Translation Bridge program to develop its AI acoustic belt.
Noisy Guts has successfully been awarded funding under the Federal Government’s $22.3 million BioMedical Translation Bridge program.
The WA med startup is one of eight medical projects nationally and the only Western Australian one to receive support to translate its innovation into a market-ready product.
Originally spun out of UWA research, the company has been awarded $1 million to support the development of its non-invasive acoustic belt that listens, records and decodes gut noises.
The tech uses artificial intelligence to diagnose and monitor common gut disorders, including irritable bowel syndrome.
Dr Josephine Muir, CEO and co-founder of Noisy Guts, said the team was thrilled to be awarded funding through the BTB program.
“This investment reflects the quality of our clinical data, our traction and confidence in our execution plan to bring our acoustic belt to market,” Josephine said.
“Noisy Guts is on a mission to radically transform global gut health and we are really looking forward to seeing this device enter the market.”Dr Josephine Muir, CEO
The team’s first application target is Irritable Bowel Syndrome (IBS) – a chronic and debilitating gut disorder affecting 11% of the world’s population and up to 1 in 5 Australians.
The latest clinical data finds that Noisy Guts’ acoustic belt diagnoses IBS with over 90% accuracy.
The BTB program is a $22.3 million initiative that will fund up to $1 million in matched funding to nurture the translation of new therapies, technologies and medical devices. The funding amount of up to $1 million is conditional on Noisy Guts entering into a Funding Agreement with MTPConnect.
MAIN IMAGE: Noisy Guts co-founder Dr Mary Webberley pitching at Freo Startup Fest this month, with ‘Flora’. Photo: Bec Walton, West Tech Fest.